Preclinical experiments revealed that (Trop2/PD-L1)-CAR-T cells significantly enhanced the killing effect on gastric cancer cells when compared to Trop2-CAR-T cells or PD-L1-CAR-T cells. Here, TACSTD2 is linked to gastric cancer.